Supplementary_Material_file_NIRVANA-1_trial.docx (26.41 kB)

NIRVANA-1: Maintenance therapy with niraparib versus niraparib –bevacizumab in patients with advanced ovarian cancer - supplementary material

dataset

posted on 2023-08-31, 13:37 authored by Syrine Sghaier, Pauline Corbaux, Isabelle Ray-Coquard, Myong Cheol Lim, Kosei Hasegawa, Els Van Nieuwenhuysen, Antonio Gonzalez, Francesco Raspagliesi, Gilles Freyer

Criteria for discontinuing allocated interventions for participant and dose modifications

History

Usage metrics

Keywords

advanced ovarian cancer bevacizumab maintenance niraparib

Licence

CC BY-NC-ND 4.0

NIRVANA-1: Maintenance therapy with niraparib versus niraparib –bevacizumab in patients with advanced ovarian cancer - supplementary material

History

Usage metrics

Categories

Keywords

Licence

Exports